News

Boehringer will look after the production of E. coli strains and manufacturing of tox and clinical stage material for multiple DARPin products. Boehringer Ingelheim biopharmaceuticals corporate senior vice

The antibiotic, AeroVanc, is a proprietary inhaled dry powder form of vancomycin in a capsule-based device designed for convenient self-administration. In Phase I studies, AeroVanc was well tolerated

Upon receiving the license, Boehringer will install the technology at its microbial facility in Vienna, Austria, which will be used for developing biopharmaceutical production processes. Boehringer Ingelheim process

GeNOsyl nitric oxide is a vasodilator which is indicated for the treatment of term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or

The product offered in a latex-free vial is generic equivalent to the carbonic anhydrase inhibitor Diamox. Acetazolamide for Injection features Sagent’s PreventIV Measures packaging and labeling, which intends

The royalty-free cell lines are based on biopharmaceutical CHO platform of DG44 and K1 cell lines. New cell lines fitting clinical and commercial production, are optimized for improved

Since Aptuit took over Verona site from GSK in 2010, it had 50 audits and carried out work for more than 90 clients. Aptuit chairman Timothy Tyson said

Forxigatm, available as once-daily tablet, is used in combination with other treatments, if adequate blood glucose control in patients is not provided, with insulin and together with diet

The solution, Patient Document Repository (PDR), provides real-time access to patient documentation in both structured and unstructured formats and ensures that the most up-to-date patient information is available